Suppr超能文献

五名 PROP1 基因突变患者的垂体功能减退症:长期自然病程以及在中年引入生长激素替代治疗的效果。

Hypopituitarism in five PROP1 mutation siblings: long-lasting natural course and the effects of growth hormone replacement introduction in middle adulthood.

机构信息

Neuroendocrine Department, Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Centre of Serbia, Dr Subotic 13, 11000, Belgrade, Serbia.

Faculty of Medicine, University Belgrade, Belgrade, Serbia.

出版信息

Pituitary. 2020 Aug;23(4):400-408. doi: 10.1007/s11102-020-01049-9.

Abstract

Twenty years after the first description of combined hypopituitarism (CPHD) caused by PROP1 mutations, the phenotype of affected subjects is still challenging for clinicians. These patients suffer from pituitary hormone deficits ranging from IGHD to panhypopituitarism. ACTH deficiency usually develops later in life. Pituitary size is variable. PROP1 mutation is the most frequent in familial congenital hypopituitarism (CH). Reports on initiation of hormonal replacement including growth hormone (GH) in adults with CH are scarce. We identified 5 adult siblings with CPHD due to PROP1 mutation (301-302delAG), aged 36-51 years (4 females), never treated for hormone deficiencies. They presented with short stature (SD from - 3.7 to - 4.7), infantile sexual characteristic, moderate abdominal obesity and low bone mineral density in 3 of them. Complete hypopituituitarism was confirmed in three siblings, while two remaining demonstrated GH, TSH, FSH and LH deficiencies. Required hormonal replacement including rhGH was initiated in all patients. After several months necessity for hydrocortisone replacement developed in all patients. After 2 years of continual replacement therapy, BMD and body composition (measured by DXA-dual X-ray absorptiometry) improved in all subjects, most prominently in two younger females and the male sibling. Besides rhGH therapy, these three patients have received sex hormones contributing to the favorable effect. The male sibling was diagnosed with brain glioblastoma two years following complete hormonal replacement. This report provides important experience regarding hormonal replacement, particularly rhGH treatment, in adults with long-term untreated CH. Beneficial effect of such therapy are widely acknowledged, yet these subjects could be susceptible to certain risks of hormonal treatment initiated in adulthood. Careful and continual clinical follow-up is thus strongly advised.

摘要

二十年前首次描述了由 PROP1 突变引起的联合垂体功能减退症(CPHD)后,受影响患者的表型仍然对临床医生具有挑战性。这些患者患有从 IGHD 到全垂体功能减退症的垂体激素缺乏症。ACTH 缺乏症通常在生命后期发展。垂体大小不一。PROP1 突变是家族性先天性垂体功能减退症(CH)中最常见的。关于在成人 CH 中启动包括生长激素(GH)在内的激素替代治疗的报告很少。我们发现了 5 名因 PROP1 突变(301-302delAG)而患有 CPHD 的成年兄弟姐妹,年龄在 36-51 岁(4 名女性),从未接受过激素缺乏症的治疗。他们表现为身材矮小(SD 为-3.7 至-4.7),婴儿期性特征,中度腹部肥胖和 3 名患者中的低骨密度。3 名兄弟姐妹被确诊为完全垂体功能减退症,而另外 2 名患者则显示 GH、TSH、FSH 和 LH 缺乏症。所有患者均开始进行必需的激素替代治疗,包括 rhGH。几个月后,所有患者均需要补充氢化可的松。在持续替代治疗 2 年后,所有患者的 BMD 和身体成分(通过 DXA-双能 X 线吸收法测量)均得到改善,其中 2 名年轻女性和男性患者的改善最为明显。除了 rhGH 治疗外,这 3 名患者还接受了性激素治疗,这有助于取得良好效果。该男性患者在完全接受激素替代治疗后两年被诊断出患有脑胶质母细胞瘤。该报告提供了有关长期未经治疗的 CH 成人的激素替代治疗,特别是 rhGH 治疗的重要经验。这种治疗的有益效果已得到广泛认可,但这些患者可能容易受到成年后开始的激素治疗的某些风险的影响。因此,强烈建议进行仔细和持续的临床随访。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验